Market Exclusive

Align Technology, Inc. (NASDAQ:ALGN) gets downgraded to Neutral by Bank of America

Analyst Ratings For Align Technology, Inc. (NASDAQ:ALGN)

Today, Align Technology, Inc. (NASDAQ:ALGN) stock was downgraded by Bank of America from Buy to Neutral.

There are 10 Buy Ratings, 3 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Align Technology, Inc. (NASDAQ:ALGN) is Buy with a consensus target price of $312.20 per share, a potential 56.99% upside.

Some recent analyst ratings include

About Align Technology, Inc. (NASDAQ:ALGN)
Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as compliance indicators and compensation for tooth eruption; Invisalign Assist treatment, which offers support to dental practitioners throughout the treatment process, including progress tracking; and Invisalign First Phase I and Invisalign First Comprehensive Phase II package for younger patients with early mixed dentition with a mixture of primary/baby and permanent teeth. Read More…

Recent Trading Activity for Align Technology, Inc. (NASDAQ:ALGN)
Shares of Align Technology, Inc. closed the previous trading session at 199.31 −75.85 27.56% with shares trading hands.

Exit mobile version